Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

Novartis AG (NOVNtah)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Novartis historical data, for real-time data please try another search
79.2000 0.0000    0.00%
04/02 - Real-time Data. Currency in EUR ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 77.9200 - 80.3800
Type:  Equity
Market:  Italy
ISIN:  CH0012005267 
Novartis 79.2000 0.0000 0.00%

NOVNtah Recent Sentiments

 
User's sentiments regarding Novartis shares are displayed on both charts showing different time periods and in a detailed table.

Assess users' predictions on whether they expect NOVN shares to be bearish or bullish and add your investment views to the bearish or bullish futures discussion for Novartis.
Start Date Username Call Open Rate End Date Chg. %
Nov 03, 2021 Antonio Magrini   79.2000 Nov 08, 2021 @ 79.2000 0.00%
Jun 01, 2021 Eric Borda   79.2000 Jun 07, 2021 @ 79.2000 0.00%
May 20, 2021 Eric Borda   79.2000 May 24, 2021 @ 79.2000 0.00%
Mar 09, 2021 Antonio Magrini   79.2000 Apr 02, 2021 @ 79.2000 0.00%
Mar 05, 2021 Vincenzo Ambrosio   79.2000 Mar 26, 2021 @ 79.2000 0.00%
Mar 05, 2021 Tiziana Cavestro   79.2000 Mar 26, 2021 @ 79.2000 0.00%
Mar 04, 2021 Vanni Mancini   79.2000 Mar 26, 2021 @ 79.2000 0.00%
Dec 16, 2020 bruno casanova   79.2000 Jan 08, 2021 @ 79.2000 0.00%
Oct 29, 2020 Franco Fantinelli   79.2000 Nov 20, 2020 @ 79.2000 0.00%
Jul 28, 2020 Leonardo Loverini   79.2000 Aug 21, 2020 @ 79.2000 0.00%
Feb 24, 2020 Giuseppe Aluia   79.2000 Mar 20, 2020 @ 79.2000 0.00%
Feb 21, 2020 Alessandro Denini   79.2000 Mar 13, 2020 @ 79.2000 0.00%
Jan 29, 2020 Mario Alberti   77.9200 Feb 21, 2020 @ 79.2000 +1.64%
Jan 24, 2020 fabio dinepi   77.9200 Feb 14, 2020 @ 79.2000 +1.64%
Dec 16, 2019 Francesco Buono   77.9200 Jan 10, 2020 @ 77.9200 0.00%
Nov 12, 2019 Ulisse Lelli   77.9200 Dec 06, 2019 @ 77.9200 0.00%
Nov 08, 2019 Mario Zanardelli   77.9200 Nov 29, 2019 @ 77.9200 0.00%
Oct 18, 2019 Giovanni Bavutti   77.9200 Nov 08, 2019 @ 77.9200 0.00%
Sep 26, 2019 Antonio Magrini   77.9200 Oct 18, 2019 @ 77.9200 0.00%
Sep 23, 2019 Massimo Ravanelli   77.9200 Oct 18, 2019 @ 77.9200 0.00%
Jul 25, 2019 Alessandro Denini   77.9200 Aug 16, 2019 @ 77.9200 0.00%
Jul 24, 2019 stefano serena   77.9200 Aug 16, 2019 @ 77.9200 0.00%
Jun 14, 2019 Antonio Magrini   79.5800 Jul 05, 2019 @ 77.9200 +2.09%
May 17, 2019 Anita Vacca   74.4400 May 20, 2019 @ 74.2600 +0.24%
May 13, 2019 Anita Vacca   72.6600 May 13, 2019 @ 71.8200 +1.16%
Apr 18, 2019 Luca Maso   68.8800 May 10, 2019 @ 72.6600 -5.49%
Apr 18, 2019 Anita Vacca   66.2000 May 10, 2019 @ 72.6600 -9.76%
Apr 17, 2019 Pietro Dipasquale   69.6800 May 10, 2019 @ 72.6600 +4.28%
Apr 12, 2019 DANILO SCHIAVINI   71.0000 May 03, 2019 @ 73.7000 +3.80%
Apr 12, 2019 Luca Maso   71.9400 Apr 18, 2019 @ 68.9400 +4.17%
Apr 12, 2019 Gianluigi Sommaruga   69.6400 May 03, 2019 @ 73.7000 +5.83%
Apr 10, 2019 Alberto Pala   75.0000 May 03, 2019 @ 73.7000 -1.73%
Mar 26, 2019 Antonio Magrini   83.8400 Apr 19, 2019 @ 68.8000 +17.94%
Mar 19, 2019 Davide Guerri   82.1000 Apr 12, 2019 @ 71.3600 -13.08%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NOVN Price Commentary

Write your thoughts about Novartis AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Lee Taylor
Lee Taylor Dec 01, 2021 10:39
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Novartis is trading at a value last seen in 2018; the funds released from a Sandoz divestment need to be directed towards further patient innovation from this Swiss Pharma major …
Lukas Bednall
Lukas Bednall Sep 28, 2021 15:36
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hi Guys, I have been invested in Novartis for 5 years and have closely followed the pharmaceutical industry for years. I have been very disappointed with the returns and am looking to transfer my portfolio into riskier assets. Upon research, I think I may have found an even better pharmaceutical company going by the name of SpectrumX. SpectrumX are leaders in patented shielded HOCL formulations that have numerous applications in medical/pharma fields. They have also undergone 2 clinical trials for Covid-19 treatment (apparently not factored into the company valuation.) To me this company seems to be on track for high growth after the IPO, however I may be getting lost in the hype. Would love to hear people's thoughts on the stock as I am keen to invest early.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email